Search research articles
Contact Us
Filters
Showing results (211-220 of 304) with videos related to
Page
of 31
Sort By:
JHEP Reports : Innovation in Hepatology
|
January 16, 2026
FGF1 ameliorates hepatic steatosis through acute activation of the unfolded protein response and VLDL production
Tim van Zutphen, Dicky Struik, Weilin Liu, et al.
Cell Reports
|
March 8, 2018
ERRγ Promotes Angiogenesis, Mitochondrial Biogenesis, and Oxidative Remodeling in PGC1α/β-Deficient Muscle
Weiwei Fan, Nanhai He, Chun Shi Lin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 14, 2008
PPARdelta regulates multiple proinflammatory pathways to suppress atherosclerosis
Grant D Barish, Annette R Atkins, Michael Downes, et al.
Open Heart
|
December 19, 2025
Pooled randomised QUARTET trials assessing effectiveness of a single pill for hypertension
Simone Marschner, Mark D Huffman, Desi Quintans, et al.
Cell Metabolism
|
April 15, 2016
ERRγ Is Required for the Metabolic Maturation of Therapeutically Functional Glucose-Responsive β Cells
Eiji Yoshihara, Zong Wei, Chun Shi Lin, et al.
Heliyon
|
July 18, 2024
Elucidating the mechano-molecular dynamics of TRAP activity using CRISPR/Cas9 mediated fluorescent reporter mice
Dilara Yılmaz, Francisco C Marques, Yannick Fischer, et al.
Biological Psychiatry
|
July 22, 2023
Alteration of DNA Methylation and Epigenetic Scores Associated With Features of Schizophrenia and Common Variant Genetic Risk
Dylan J Kiltschewskij, William R Reay, Michael P Geaghan, et al.
Cell Metabolism
|
May 4, 2017
PPARδ Promotes Running Endurance by Preserving Glucose
Weiwei Fan, Wanda Waizenegger, Chun Shi Lin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 14, 2008
PPARdelta-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosis
Yasunori Takata, Joey Liu, Fen Yin, et al.
American Heart Journal
|
October 5, 2020
Ultra-low-dose quadruple combination blood pressure-lowering therapy in patients with hypertension: The QUARTET randomized controlled trial protocol
Clara K Chow, Emily R Atkins, Laurent Billot, et al.
Page
of 31
Search research articles
Search
Showing results (211-220 of 304) with videos related to
Sort By:
Page
of 31
JHEP Reports : Innovation in Hepatology
|
January 16, 2026
FGF1 ameliorates hepatic steatosis through acute activation of the unfolded protein response and VLDL production
Tim van Zutphen, Dicky Struik, Weilin Liu, et al.
Cell Reports
|
March 8, 2018
ERRγ Promotes Angiogenesis, Mitochondrial Biogenesis, and Oxidative Remodeling in PGC1α/β-Deficient Muscle
Weiwei Fan, Nanhai He, Chun Shi Lin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 14, 2008
PPARdelta regulates multiple proinflammatory pathways to suppress atherosclerosis
Grant D Barish, Annette R Atkins, Michael Downes, et al.
Open Heart
|
December 19, 2025
Pooled randomised QUARTET trials assessing effectiveness of a single pill for hypertension
Simone Marschner, Mark D Huffman, Desi Quintans, et al.
Cell Metabolism
|
April 15, 2016
ERRγ Is Required for the Metabolic Maturation of Therapeutically Functional Glucose-Responsive β Cells
Eiji Yoshihara, Zong Wei, Chun Shi Lin, et al.
Heliyon
|
July 18, 2024
Elucidating the mechano-molecular dynamics of TRAP activity using CRISPR/Cas9 mediated fluorescent reporter mice
Dilara Yılmaz, Francisco C Marques, Yannick Fischer, et al.
Biological Psychiatry
|
July 22, 2023
Alteration of DNA Methylation and Epigenetic Scores Associated With Features of Schizophrenia and Common Variant Genetic Risk
Dylan J Kiltschewskij, William R Reay, Michael P Geaghan, et al.
Cell Metabolism
|
May 4, 2017
PPARδ Promotes Running Endurance by Preserving Glucose
Weiwei Fan, Wanda Waizenegger, Chun Shi Lin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 14, 2008
PPARdelta-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosis
Yasunori Takata, Joey Liu, Fen Yin, et al.
American Heart Journal
|
October 5, 2020
Ultra-low-dose quadruple combination blood pressure-lowering therapy in patients with hypertension: The QUARTET randomized controlled trial protocol
Clara K Chow, Emily R Atkins, Laurent Billot, et al.
Page
of 31